网站主页>>>项目整合>>>项目整合精选
聚焦新型临床类新产品的整合与转化. 在创新药研发领域,传统的“单一产品、单打独斗”模式正在被一种更系统化的“项目整合”思维所取代。项目整合的核心,在于将散落在研发早期、中期的创新资产,通过资金、临床资源、产业生态等多维度要素的有机组合,实现从“科学发现”到“临床价值”,再到“商业成功”的跨越。研发与商业的战略整合:从“资产思维”到“组合思维”它要求我们超越单个分子的视野,拥抱一个由技术创新、临床需求、资本支持和商业洞察共同构成的复杂网络。在这个网络中,成功的标准不再是单一的“获批上市”,而是能否通过高效的整合,将科学上的突破,转化为临床上真正可及、商业上可持续、能够惠及患者的解决方案。近年来,药物发现已从传统的小分子化药拓展至更多元的分子类型,这些新型API在项目整合中呈现出独特的开发范式,项目整合的核心挑战在于递送系统的设计与肝外靶向能力的突破。
如有产品相关项目调研推广服务, 请致函联系我们

客户展示

示例图片

项目整合精选

  • NSC-724771, JS-K

    4-[(Z)-(2,4-二硝基苯氧基)-氧偶氮基]-1-哌嗪羧酸乙酯Chemical Name: 4-(2,4-Dinitrophenoxy)-NNO-azoxy]piperazine-1-carboxylic acid ethyl ester
    CAS No. 205432-12-8
    项目整合开发状态: Preclinical
    项目研究机构: National Cancer In...
    参考文献标题:O2-Arylated or O2-glycosylated 1-substd.diazen-1-ium-1,2-diolates and O2-substd.1-[(2-carboxylato)pyrrolidin-1-yl]diazen-1-ium-1,2-diolates
    文献作者:Keefer,L.K.; Saavedra,J.E.; Srinivasan,A.; Rice,W.G.; Bogdan,C.; Ji,X.(US Department of Health & Human Services)
    参考来源:JP 2002506421; WO 9813358

  • L-755507

    4-[(己基氨基甲酰)氨基]-N-[4-(2-{[(2S)-2-羟基-3-(4-羟基苯氧基)丙基]氨基}乙基)苯基]苯磺酰胺Chemical Name: 4-(3-Hexylureido)-N-[4-[2-[2(S)-hydroxy-3-(4-hydroxyphenoxy)propylamino]ethyl]phenyl]benzenesulfonamide
    CAS No. 159182-4...
    参考文献标题:Substd.phenyl sulfonamides as selective beta3 agonists for the treatment of diabetes and obesity
    文献作者:Fisher,M.H.; Mathvink,R.J.; Ok,H.O.; Parmee,E.R.; Weber,A.E.(Merck & Co.,Inc.)
    参考来源:CA 2114712; EP 0611003; JP 1995010827; US 5451677; WO 9418161

  • RO-1130830, RS-130830

    4-[[[4-(4-氯苯氧基)苯基]磺酰基]甲基]四氢-n-羟基-2H-吡喃-4-羧酰胺Chemical Name: 4-[4-(4-Chlorophenoxy)phenylsulfonylmethyl]tetrahydropyran-4-carbohydroxamic acid; 4-[4-(4-Chlorophenoxy)phenylsulfonylmethyl]-N-hydroxytetra...
    参考文献标题:Metalloproteinase inhibitors,pharmaceutical compsns.containing them and their pharmaceutical uses,and methods and intermediates useful for their preparation
    文献作者:Zook,S.E.; Dagnino,R.Jr.; Deason,M.E.; Bender,S.L.; Melnick,M.J.(Agouron Pharmaceuticals,Inc.)
    参考来源:EP 0874830; JP 2000502330; WO 9720824

  • CB-300919

    4-[[[7-氯-3,4-二氢-3-甲基-2-[(4-甲基-1-哌嗪基)甲基]-4-氧代-6-喹唑啉基]甲基]-2-丙炔-1-基氨基]-N-(3-吡啶基甲基)苯甲酰胺Chemical Name: 4-[N-[7-Chloro-3-methyl-2-(4-methylpiperazin-1-ylmethyl)-4-oxo-3,4-dihydroquinazolin-6-ylmethyl]-N-(2-...
    参考文献标题:Anti-cancer dihydroquinazoline derivs.
    文献作者:Bavetsias,V.; Jackman,A.; Skelton,L.(Cancer Research Campaign Technology Ltd.)
    参考来源:WO 0050417

  • Reglitazar, PNU-182716, JTT-501

    4-[[4-[2-(5-甲基-2-苯基-1,3-恶唑-4-基)乙氧基]苯基]甲基]-1,2-恶唑烷-3,5-二酮Chemical Name: 4-[4-[2-(5-Methyl-2-phenyl-4-oxazolyl)ethoxy]benzyl]isoxazolidine-3,5-dione
    CAS No. 170861-63-9
    项目整合开发状态: Discontinued
    项...
    参考文献标题:Isoxazolidinedione deriv.and use thereof
    文献作者:Shinkai,H.(Japan Tobacco Inc.)
    参考来源:EP 0684242; JP 1996517913; US 5728720; US 6057343; WO 9518125

  • AG-12286

    4-[[4-氨基-5-(2,6-二氟苯甲酰基)-1,3-噻唑-2-基]氨基]苯磺酰胺Chemical Name: 4-[4-Amino-5-(2,6-difluorobenzoyl)thiazol-2-ylamino]benzenesulfonamide
    CAS No. 223784-75-6
    项目整合开发状态: Biological Testing
    项目研究机构: Agouro...
    参考文献标题:4-Aminothiazole derivs.,their preparation and their use as inhibitors of cyclin-dependent kinases
    文献作者:Yang,Y.; Xiao,W.; Chu,S.S.; Li,L.; Chong,W.K.M.; Duvadie,R.R.(Agouron Pharmaceuticals,Inc.)
    参考来源:WO 9921845

  • YM-17551

    4-[[5-[(4-乙酰基-3-羟基-2-丙基苯基)甲基硫烷基]-1,3,4-噻二唑-2-基]硫烷基甲基]苯甲酸Chemical Name: 4-[5-(4-Acetyl-3-hydroxy-2-propylbenzylthio)-1,3,4-thiadiazol-2-ylthiomethyl]benzoic acid
    CAS No. 107859-85-8
    项目整合开发状态: Pre...
    参考文献标题:(Substd.benzyl)thio heterocyclic cpds.having leukotriene-antagonist activity
    文献作者:Mase,T.; Murase,K.; Tsuzuki,R.; Tomioka,K.; Hara,H.(Yamanouchi Pharmaceutical Co.,Ltd.)
    参考来源:EP 0214732; US 4803211; US 4933348; US 5180730

  • SM-18163

    4-[1-(1,3-苯并二噁唑-5-基羰基)哌啶-4-基]-6-(4-甲氧苄基)嘧啶-2-胺Chemical Name: 4-[1-(1,3-Benzodioxol-5-ylcarbonyl)piperidin-4-yl]-6-(4-methoxybenzyl)pyrimidin-2-amine; 1-[4-[2-Amino-6-(4-methoxybenzyl)pyrimidin-4-yl]pi...
    参考文献标题:Piperidinylpyramidine derivs.
    文献作者:Fujiwara,N.; Ueda,Y.; Murata,S.; Hirota,F.; Kawakami,H.; Fujita,H.(Sumitomo Pharmaceuticals Co.,Ltd.)
    参考来源:EP 0892795; JP 2001511764; US 5948786; WO 9738992

  • SM-8849

    4-[1-(3-氟-4-苯基苯基)乙基]-N-甲基-1,3-噻唑-2-胺Chemical Name: 4-[1-(2-Fluorobiphenyl-4-yl)ethyl]-N-methylthiazole-2-amine; 4-[1-(2-Fluorobiphenyl-4-yl)ethyl]-2-(methylamino)thiazole
    CAS No. 113759-19-6
    项目整...
    参考文献标题:Aminazole derivatives and their production and use
    文献作者:Ozato,Y.; Tamura,N.; Masumori,H.; Yamamoto,M.; Kojima,A.; Nishikakau,F.; Kimura,Y.(Sumitomo Pharmaceuticals Co.,Ltd.)
    参考来源:EP 0248399; JP 1988152368; JP 1993247014; US 4914112; US 5066666; US 5180731

  • 新产品编号:206169

    4-[2-(4-氟苯基)-5-(1-甲基-4-哌啶基)-1H-吡咯-3-基]吡啶Chemical Name: 4-[2-(4-Fluorophenyl)-5-(1-methylpiperidin-4-yl)-1H-pyrrol-3-yl]pyridine
    CAS No. 188343-77-3
    项目整合开发状态: Preclinical
    项目研究机构: Merck & Co. (...
    参考文献标题:2-Substd.aryl pyrroles,compsns.containing such cpds.and methods of use
    文献作者:De Laszlo,S.E.; Mantlo,N.B.; Ponticello,G.S.; Selnick,H.G.; Liverton,N.J.(Merck & Co.,Inc.)
    参考来源:EP 0863757; JP 1999510510; US 5792778; WO 9705877

  • 免费注册, 助力研发,生产, 销售.

    招募中心

    我们的宗旨: 净化, 简洁, 高效Purifying, concise, efficient !我们的口号: 减少中间商赚差价!

    即日起可免费注册成为会员, 建立企业产品库, 免费上传产品目录, 企业介绍等. 让你的产品直接呈现给客户.

    试运营阶段,所有广告业务5折优惠

    分类广告投放

    依据化学成分的不同, 针对不同的企业和产品, 我们提供分类产品广告投放.

    客户展示

    示例图片
    优秀企业推荐
    ×

    通知